Corvia Medical Inc
Corvia Medical Inc. is a medical device company focused on transforming the treatment of heart failure. The company is advancing the Corvia® Atrial Shunt, which is currently undergoing the RESPONDER-HF trial, a significant study aimed at securing FDA approval for its use as a breakthrough treatment for heart failure with preserved and mildly reduced ejection fraction (HFpEF/HFmrEF).
Leadership & Board
- Current Number of Employees
- 30
- Current LinkedIn Followers
- 3,653
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $55M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $55M
- Latest Funding Round
- Investment
- Post-Money Valuation
- ―
Employee Trend
Corvia Medical Inc had 30 employees as of October 12, 2026. The number of employees decreased by 2 (6.25%) week-over-week.
Social Trend
Corvia Medical Inc had 3,653 followers as of October 12, 2026. The number of followers increased by 6 (0.16%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jun 17, 2025 | Investment | $55.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Lumira Ventures | Investment |
| Third Rock Ventures | Investment |
| General Catalyst Partners | Investment |
| AccelMed | Investment |
Similar Companies
A snapshot of private companies similar to Corvia Medical Inc, helping you discover and navigate related company profiles.
Related News and Analysis
